CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Beijing Beilu Pharmaceutical Company Limited Company Snapshot
Beijing Beilu Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Beilu Pharmaceutical Company Limited with three other companies in this sector in China: Zhejiang Shapuaisi Pharmaceutical Co Ltd (2018 sales of 607.34 million Chinese Renmimbi [US$86.29 million] of which 54% was Eye drops), Wuhan Hiteck Biological Pharma Co Ltd (590.87 million Chinese Renmimbi [US$83.95 million] of which 93% was Medicine Manufacture), and Hainan Poly Pharm Co Ltd (623.90 million Chinese Renmimbi [US$88.64 million] of which 39% was Antiallergic drugs).

Sales Analysis. Beijing Beilu Pharmaceutical Company Limited reported sales of 608.05 million Chinese Renmimbi (US$86.39 million) for the year ending December of 2018. This represents an increase of 16.4% versus 2017, when the company's sales were 522.54 million Chinese Renmimbi. Sales at Beijing Beilu Pharmaceutical Company Limited have increased during each of the previous five years (and since 2013, sales have increased a total of 83%). Sales of Pharmaceutical Sales saw an increase of 16.5% in 2018, from 519.81 million Chinese Renmimbi to 605.55 million Chinese Renmimbi. Not all segments of Beijing Beilu Pharmaceutical Company Limited experienced an increase in sales in 2018: sales of Other Operation fell 8.1% to 2.50 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Beijing Beilu Pharmaceutical Company Limited
  Stock Performance Chart for Beijing Beilu Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (12/13/2019): 8.26
(Figures in Chinese Renmimbi)
1 Week 0.9%   13 Weeks -0.2%  
4 Weeks -14.0%   52 Weeks 17.7%  
 
Beijing Beilu Pharmaceutical Company Limited Key Data:
  Ticker: 300016 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 608,053,473
(Year Ending Jan 2019).
Employees: 535
  Currency: Chinese Renmimbi Market Cap: 4,039,056,376
  Fiscal Yr Ends: December Shares Outstanding: 488,989,876
  Share Type: A Gu Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.